Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moors & Cabot Inc. lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,814 shares of the biopharmaceutical company’s stock after selling 1,482 shares during the quarter. Moors […]
Oppenheimer Asset Management Inc. boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 172,585 shares of the biopharmaceutical company’s stock after buying an additional 5,798 shares during the quarter. […]
Clearstead Advisors LLC increased its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 19.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,315 shares of the biopharmaceutical company’s stock after purchasing an additional 537 shares during the quarter. Clearstead […]
Atria Investments Inc decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,826 shares of the biopharmaceutical company’s stock after selling 485 shares […]
Cobblestone Capital Advisors LLC NY decreased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 28.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,700 shares of the biopharmaceutical company’s stock after selling 1,072 shares during the […]